Chinax ENT UK Ltd Filleted Accounts Cover |
Company No. 10861263 | |||||||||
Chinax ENT UK Ltd Directors Report Registrar |
The Director presents his report and the accounts for the year ended 31 July 2024. | |||||||||
Principal activities | |||||||||
Director | |||||||||
The Director who served at any time during the year was as follows: | |||||||||
E.C. Aneke | |||||||||
Signed on behalf of the board | |||||||||
E.C. Aneke | |||||||||
Director | |||||||||
18 September 2024 |
Chinax ENT UK Ltd Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2024 | 2023 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 4 | |||||||||
Current assets | ||||||||||
Debtors | ||||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | ( | ( | ||||||||
Net current assets/(liabilities) | ( | |||||||||
Total assets less current liabilities | ( | |||||||||
Provisions for liabilities | ||||||||||
Deferred taxation | ( | ( | ||||||||
Net assets/(liabilities) | ( | |||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 6 | ( | ||||||||
Total equity | ( | |||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 18 September 2024 and signed on its behalf by: | ||||||||||
E.C. Aneke | ||||||||||
Director | ||||||||||
18 September 2024 |
Chinax ENT UK Ltd Notes to the Accounts Registrar |
for the year ended 31 July 2024 | ||||||||||||||
1 | General information | |||||||||||||
Chinax ENT UK Ltd is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||
Its registered number is: 10861263 | ||||||||||||||
Its registered office is: | ||||||||||||||
2 | Accounting policies | |||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Plant and machinery | ||||||||||||||
3 | Employees | |||||||||||||
2024 | 2023 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Tangible fixed assets | |||||||||||||
Total | ||||||||||||||
£ | ||||||||||||||
Cost or revaluation | ||||||||||||||
At 1 August 2023 | ||||||||||||||
Additions | ||||||||||||||
At 31 July 2024 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 August 2023 | ||||||||||||||
Charge for the year | ||||||||||||||
At 31 July 2024 | ||||||||||||||
Net book values | ||||||||||||||
At 31 July 2024 | ||||||||||||||
At 31 July 2023 | ||||||||||||||
5 | Share Capital | |||||||||||||
£1.00 Ordinary shares | ||||||||||||||
6 | Reserves | |||||||||||||